Profund Advisors LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Profund Advisors LLC

  • $2.59 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$17.63 - $21.74 $108,212 - $133,440
6,138 Added 38.63%
22,026 $434,000
Q4 2023

Feb 14, 2024
SELL
$14.37 - $19.07 $109,470 - $145,275
-7,618 Reduced 32.41%
15,888 $278,000
Q3 2023

Nov 13, 2023
BUY
$13.62 - $20.2 $23,154 - $34,340
1,700 Added 7.8%
23,506 $408,000
Q2 2023

Aug 10, 2023
SELL
$10.44 - $16.48 $24,043 - $37,953
-2,303 Reduced 9.55%
21,806 $307,000
Q1 2023

May 11, 2023
BUY
$10.7 - $15.79 $257,966 - $380,681
24,109 New
24,109 $259,000

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $687M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email